Log In
Print
BCIQ
Print
Print this Print this
 

Zubsolv, buprenorphine/naloxone (OX219)

Also known as: formerly PKX219

  Manage Alerts
Collapse Summary General Information
Company Orexo AB
DescriptionSublingual tablet formulation of buprenorphine and naloxone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAddiction
Indication DetailsInduction treatment of opioid dependence; Maintenance treatment of opioid dependence; Treat opioid dependence
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today